Precision Medicine Platforms
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 AZN | AstraZeneca PLC | $287.9b | $185.08 | +1.8% | 2.3M |
 TMO | Thermo Fisher Scientific, Inc. | $183.0b | $471.55 | -2.2% | 1.7M |
 DHR | Danaher Corporation | $129.3b | $183.90 | -1.5% | 3.3M |
 WAT | Waters Corp | $37.7b | $364.80 | -3.1% | 676.5K |
 GH | Guardant Health, Inc. Common Stock | $17.2b | $125.55 | -5.6% | 3.3M |
 BBIO | BridgeBio Pharma, Inc. Common Stock | $13.0b | $67.61 | +0.4% | 2.6M |
 RVTY | Revvity, Inc. | $11.7b | $98.37 | -3.9% | 868.6K |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $9.8b | $253.97 | -4.1% | 617.7K |
 TEM | Tempus AI, Inc. Class A Common Stock | $9.1b | $46.19 | -11.6% | 8.9M |
 NUVL | Nuvalent, Inc. Class A Common Stock | $8.7b | $90.84 | -3.4% | 716.0K |
 TECH | Bio-Techne Corp. | $8.1b | $51.98 | -2.3% | 2.9M |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $6.7b | $74.12 | -0.7% | 639.5K |
 LNTH | Lantheus Holdings, Inc | $6.5b | $100.97 | -1.8% | 746.3K |
 CAI | Caris Life Sciences, Inc. Common Stock | $4.7b | $16.51 | -4.5% | 2.7M |
 TWST | Twist Bioscience Corporation Common Stock | $4.2b | $69.19 | -6.4% | 2.5M |
 DYN | Dyne Therapeutics, Inc. Common Stock | $3.2b | $17.05 | -7.4% | 1.9M |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | $2.6b | $28.30 | -3.2% | 710.9K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $2.4b | $16.89 | -6.6% | 2.2M |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $1.5b | $52.28 | -7.1% | 1.2M |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $24.25 | -4.5% | 445.6K |
 CDNA | CareDx, Inc. | $1.2b | $22.27 | -3.7% | 548.4K |
 AURA | Aura Biosciences, Inc. Common Stock | $0.8b | $6.63 | -2.5% | 347.1K |
 ANRO | Alto Neuroscience Inc. | $0.7b | $18.26 | -8.8% | 414.1K |
 CSTL | Castle Biosciences, Inc. Common Stock | $0.6b | $21.07 | -2.5% | 212.5K |
 CTKB | Cytek Biosciences, Inc. Common Stock | $0.5b | $4.10 | -5.3% | 912.4K |
 LAB | Standard BioTools Inc. Common Stock | $448.9m | $1.15 | -9.4% | 3.5M |
 OABI | OmniAb, Inc. Common Stock | $391.4m | $2.48 | -7.0% | 494.1K |
 SOPH | SOPHiA GENETICS SA Ordinary Shares | $362.5m | $5.01 | +1.0% | 79.7K |
 NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $348.2m | $2.38 | -11.0% | 491.5K |
 PRLD | Prelude Therapeutics Incorporated | $312.2m | $3.82 | -6.4% | 220.9K |
 AVXL | Anavex Life Sciences | $280.8m | $2.57 | -8.9% | 942.4K |
 ACIU | AC Immune SA | $270.7m | $2.24 | -6.7% | 328.1K |
 QSI | Quantum-Si Incorporated Class A Common Stock | $259.1m | $1.04 | -18.7% | 8.9M |
 NVCT | Nuvectis Pharma, Inc. Common Stock | $258.6m | $9.55 | -1.2% | 74.4K |
 FHTX | Foghorn Therapeutics Inc. Common Stock | $251.3m | $3.73 | -0.3% | 119.0K |
 BDSX | Biodesix, Inc. Common Stock | $169.0m | $15.64 | -5.2% | 33.9K |
 QTRX | Quanterix Corporation Common Stock | $144.1m | $3.29 | -13.3% | 928.1K |
 XGN | Exagen Inc. Common Stock | $120.3m | $4.29 | -10.3% | 371.2K |
 SEER | Seer, Inc. Class A Common Stock | $102.8m | $1.78 | -3.5% | 76.3K |
 IBIO | iBio, Inc. Common Stock | $94.4m | $1.82 | -5.4% | 2.3M |
 SERA | Sera Prognostics, Inc. Class A Common Stock | $84.6m | $2.23 | -0.7% | 33.8K |
 CSBR | Champions Oncology, Inc. | $81.0m | $5.67 | -1.6% | 895 |
 ACRV | Acrivon Therapeutics, Inc. Common Stock | $68.5m | $1.42 | -8.4% | 546.3K |
 MDXH | MDxHealth SA Ordinary Shares | $39.0m | $0.57 | -5.2% | 1.0M |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $33.1m | $10.26 | +4.0% | 100.6K |
 CCEL | Cryo-Cell International Inc. | $27.1m | $3.53 | +0.9% | 4.2K |
 ALLR | Allarity Therapeutics, Inc. Common Stock | $26.1m | $1.61 | -5.3% | 157.0K |
 ADVB | Advanced Biomed Inc. Common Stock | $8.2m | $4.30 | +0.9% | 6.6K |
 CDIO | Cardio Diagnostics Holdings Inc. Common stock | $5.6m | $1.98 | -6.2% | 64.8K |